Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-08-21

Clinical Trial Update: Transcranial Photobiomodulation in Anxiety Disorders [NA]

View source ↗

Summary

Clinical trial evaluating transcranial photobiomodulation for symptoms of anxiety; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas at Austin | Conditions: Symptoms of Anxiety | NA | Status: NOT_YET_RECRUITING